ipos0_l

Regeneron invest $800 million into New York facilities

pharmafile | August 15, 2019 | News story | Medical Communications East Greenbush, New York, Regeneron, pharma 

Regeneron is investing $800 million into its New York production facilities.

The firm is planning to build a four story Science Building containing labs and offices, and a six story car park with capacity for 1,020 cars, in the town of East Greenbush in New York State.

The new facility will bring 1,050 new workers to the town making it will be one of the region’s biggest employers. There will be around 4,000 and 5,000 Regeneron employees in East Greenbush overall.

According to documents filed by Jacobs, the engineering firm handling the project, “construction for the site development and two structures will take approximately 30 to 36 months.”

Louis Goss

Related Content

FDA accepts BLA for Regeneron’s linvoseltamab for Priority Review

Regeneron Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its …

Regeneron’s linvoseltamab gains EMA filing acceptance for R/R MM treatment

Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has accepted for review its …

louis-reed-pwckf7l4-no-unsplash_5

Regeneron forms Regeneron Cell Medicines with acquisition of 2seventy bio

Regeneron Pharmaceuticals has announced the formation of Regeneron Cell Medicines based on an agreement with …

Latest content